About NADJPN Life Science Co., Ltd.

NADJPN Life Science Co., Ltd. is a premier pharmaceutical-grade manufacturer and distributor of Nicotinamide Adenine Dinucleotide (NAD+) raw materials, intravenous formulations, and biosynthesis-derived API compounds. Headquartered at the Osaka Medical Center Building in Umeda, Kita-ku, Osaka, we operate from a GMP-certified production facility compliant with ISO 9001:2015 Quality Management Systems.

Our mission is to advance the science of cellular longevity by supplying pharmaceutical developers, research institutions, nutraceutical brands, and clinical compounding pharmacies with ultra-high-purity NAD+ materials — consistently, traceably, and at global scale.

We serve a strictly B2B network spanning Southeast Asia and international markets. Our clients include pharmaceutical API procurement teams, contract research organizations (CROs), clinical trial sponsors in neurodegeneration and metabolic medicine, and premium supplement manufacturers seeking precursor raw materials with full chain-of-custody documentation.

The company was founded to address a critical gap in the Asia-Pacific supply chain for sterile-grade and research-grade NAD+ compounds. Prior to NADJPN Life Science, most procurement pathways ran through intermediaries with limited transparency on synthesis methodology, batch traceability, and stability data — risks unacceptable in pharmaceutical and clinical environments.

Today, our product portfolio spans three core verticals: Pharmaceutical API for clinical trial applications, Premium Nutraceutical ingredient supply with high-bioavailability precursors, and Intravenous IV Therapy lyophilized formulations optimized for sterile compounding frameworks.

All manufacturing adheres to Good Manufacturing Practice (GMP) standards, with every batch accompanied by a Certificate of Analysis (COA), stability reports, and full lot traceability documentation suitable for regulatory submissions worldwide.